{"title":"第二波和第三波大流行期间儿童COVID-19危重疾病概况:来自南印度的单中心研究","authors":"Sangeeta V Budur, S. Thyagarajan","doi":"10.29011/2577-1515.100221","DOIUrl":null,"url":null,"abstract":"Aims : To describe the clinical characteristics of children with critical COVID-19 illness from a single tertiary referral center during the second and third waves to understand the burden of critical COVID-19 illness in children which may guide preparedness in terms of resources, training, and services. Methods: A prospective observational study of critical COVID-19 children under the age of 18 years admitted to a ten-bedded PICU during the second wave (April-July 2021) and third wave (December-February 2022) of the COVID-19 pandemic. We categorized the children into 1) Acute COVID-19 infection and 2) Multi-inflammatory Syndrome in Children - MISC (post COVID-19/MISC secondary to acute COVID-19 infection). Demographic data, clinical data, investigations, treatment given, and outcome measures were studied. Results: Seventy-six critical COVID-19 illness admissions occurred with male preponderance. Sixty-two (81%) children presented with acute COVID-19 illness, 20 in the second wave and 42 in the third wave. Respiratory symptoms (85% vs 30%) predominated during the second wave and neurological symptoms (35% vs 20%) during the third wave. Critical care interventions were higher in the second wave. Neurological comorbidity led to mortality (5% vs 2%). MISC was seen in fourteen (19%) children. Intravenous immunoglobulin and methylprednisolone were given more during the third wave (80% vs 11%). One child in each wave died (11 % vs 20%). Conclusions: The clinical profile of children with critical COVID-19 illness has been changing and becoming progressively complex and atypical during each wave with significant morbidity but with good clinical outcomes/recovery rate.","PeriodicalId":226174,"journal":{"name":"Infectious Diseases Diagnosis & Treatment","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Profile of Critical COVID-19 Illness in Children During the Second and Third Wave of the Pandemic: A Single Center Study from South India\",\"authors\":\"Sangeeta V Budur, S. Thyagarajan\",\"doi\":\"10.29011/2577-1515.100221\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aims : To describe the clinical characteristics of children with critical COVID-19 illness from a single tertiary referral center during the second and third waves to understand the burden of critical COVID-19 illness in children which may guide preparedness in terms of resources, training, and services. Methods: A prospective observational study of critical COVID-19 children under the age of 18 years admitted to a ten-bedded PICU during the second wave (April-July 2021) and third wave (December-February 2022) of the COVID-19 pandemic. We categorized the children into 1) Acute COVID-19 infection and 2) Multi-inflammatory Syndrome in Children - MISC (post COVID-19/MISC secondary to acute COVID-19 infection). Demographic data, clinical data, investigations, treatment given, and outcome measures were studied. Results: Seventy-six critical COVID-19 illness admissions occurred with male preponderance. Sixty-two (81%) children presented with acute COVID-19 illness, 20 in the second wave and 42 in the third wave. Respiratory symptoms (85% vs 30%) predominated during the second wave and neurological symptoms (35% vs 20%) during the third wave. Critical care interventions were higher in the second wave. Neurological comorbidity led to mortality (5% vs 2%). MISC was seen in fourteen (19%) children. Intravenous immunoglobulin and methylprednisolone were given more during the third wave (80% vs 11%). One child in each wave died (11 % vs 20%). Conclusions: The clinical profile of children with critical COVID-19 illness has been changing and becoming progressively complex and atypical during each wave with significant morbidity but with good clinical outcomes/recovery rate.\",\"PeriodicalId\":226174,\"journal\":{\"name\":\"Infectious Diseases Diagnosis & Treatment\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infectious Diseases Diagnosis & Treatment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29011/2577-1515.100221\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious Diseases Diagnosis & Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29011/2577-1515.100221","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:描述某三级转诊中心第二波和第三波COVID-19危重症患儿的临床特征,了解儿童COVID-19危重症的负担情况,为资源、培训和服务准备提供指导。方法:对第二波(2021年4月- 7月)和第三波(2022年12月- 2月)COVID-19大流行期间入住10床PICU的18岁以下重症儿童进行前瞻性观察研究。我们将患儿分为1)急性COVID-19感染和2)儿童多重炎症综合征- MISC(继发于急性COVID-19感染的COVID-19后/MISC)。研究了人口统计资料、临床资料、调查、给予的治疗和结果测量。结果:新冠肺炎危重入院76例,男性居多。62名(81%)儿童出现急性COVID-19疾病,20名出现第二波,42名出现第三波。呼吸道症状(85%对30%)在第二波中占主导地位,神经系统症状(35%对20%)在第三波中占主导地位。第二波重症监护干预较高。神经系统合并症导致死亡(5% vs 2%)。14例(19%)患儿出现MISC。静脉注射免疫球蛋白和甲基强的松龙在第三波给予更多(80%对11%)。每波有一名儿童死亡(11%对20%)。结论:儿童COVID-19危重症的临床特征不断变化,每一波发病均逐渐复杂和非典型,发病率显著,但临床转归/康复率良好。
Profile of Critical COVID-19 Illness in Children During the Second and Third Wave of the Pandemic: A Single Center Study from South India
Aims : To describe the clinical characteristics of children with critical COVID-19 illness from a single tertiary referral center during the second and third waves to understand the burden of critical COVID-19 illness in children which may guide preparedness in terms of resources, training, and services. Methods: A prospective observational study of critical COVID-19 children under the age of 18 years admitted to a ten-bedded PICU during the second wave (April-July 2021) and third wave (December-February 2022) of the COVID-19 pandemic. We categorized the children into 1) Acute COVID-19 infection and 2) Multi-inflammatory Syndrome in Children - MISC (post COVID-19/MISC secondary to acute COVID-19 infection). Demographic data, clinical data, investigations, treatment given, and outcome measures were studied. Results: Seventy-six critical COVID-19 illness admissions occurred with male preponderance. Sixty-two (81%) children presented with acute COVID-19 illness, 20 in the second wave and 42 in the third wave. Respiratory symptoms (85% vs 30%) predominated during the second wave and neurological symptoms (35% vs 20%) during the third wave. Critical care interventions were higher in the second wave. Neurological comorbidity led to mortality (5% vs 2%). MISC was seen in fourteen (19%) children. Intravenous immunoglobulin and methylprednisolone were given more during the third wave (80% vs 11%). One child in each wave died (11 % vs 20%). Conclusions: The clinical profile of children with critical COVID-19 illness has been changing and becoming progressively complex and atypical during each wave with significant morbidity but with good clinical outcomes/recovery rate.